BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36646381)

  • 1. Factors to Consider in Prescribing Asthma Biologic Therapies to Children.
    Anderson WC; Banzon TM; Chawes B; Papadopoulos NG; Phipatanakul W; Szefler SJ
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):693-701. PubMed ID: 36646381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics in pediatric lung disease.
    McGhee SA
    Curr Opin Pediatr; 2018 Jun; 30(3):366-371. PubMed ID: 29538045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of biologic therapies for the management of pediatric asthma.
    Lovinsky-Desir S
    Pediatr Pulmonol; 2020 Mar; 55(3):803-808. PubMed ID: 31880870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit.
    Pepper AN; Hanania NA; Humbert M; Casale TB
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1081-1088. PubMed ID: 33685606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma.
    Yılmaz İ; Paçacı Çetin G; Arslan B; Şeker S; Bozkurt Yılmaz HE; Aktaş Yapıcı E; Köylüce S; Açar E
    Tuberk Toraks; 2023 Mar; 71(1):75-93. PubMed ID: 36912412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics and severe asthma in children.
    Saxena S; Rosas-Salazar C; Fitzpatrick A; Bacharier LB
    Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):111-118. PubMed ID: 36730217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging care management strategies for severe asthma: integrating biologic therapy.
    Spjut R
    Am J Manag Care; 2022 Sep; 28(11 Suppl):S203-S209. PubMed ID: 36648385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Biologics in Asthma.
    McGregor MC; Krings JG; Nair P; Castro M
    Am J Respir Crit Care Med; 2019 Feb; 199(4):433-445. PubMed ID: 30525902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in Allergy: Are Biologic Treatment Responses in Severe Asthma the Same in Adults and Children?
    Gaberino CL; Bacharier LB; Jackson DJ
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2673-2682. PubMed ID: 37517797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics in the treatment of asthma in children and adolescents.
    Bacharier LB; Jackson DJ
    J Allergy Clin Immunol; 2023 Mar; 151(3):581-589. PubMed ID: 36702649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tempest: Difficult to Control Asthma in Adolescence.
    Burg GT; Covar R; Oland AA; Guilbert TW
    J Allergy Clin Immunol Pract; 2018; 6(3):738-748. PubMed ID: 29747981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic burden of severe asthma among US patients treated with biologic therapies.
    Reibman J; Tan L; Ambrose C; Chung Y; Desai P; Llanos JP; Moynihan M; Tkacz J
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):318-325.e2. PubMed ID: 33775904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics for severe asthma-Which, when and why?
    Shah PA; Brightling C
    Respirology; 2023 Aug; 28(8):709-721. PubMed ID: 37222237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for Severe Asthma in Children: What About Biologics?
    Pansare M; Seth D; Kamat D; Poowuttikul P
    Pediatr Ann; 2021 May; 50(5):e206-e213. PubMed ID: 34044704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies.
    Hansen S; Baastrup Søndergaard M; von Bülow A; Bjerrum AS; Schmid J; Rasmussen LM; Johnsen CR; Ingebrigtsen T; Håkansson KEJ; Johansson SL; Bisgaard M; Assing KD; Hilberg O; Ulrik C; Porsbjerg C
    Chest; 2024 Feb; 165(2):253-266. PubMed ID: 37925144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Frequently Is Asthma Objectively Demonstrated before Starting a Biologic? Quality Assessment of a Group Practice of Allergists and Immunologists.
    Dziewa I; Craig T; Al-Shaikhly T
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33352823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic?
    Anderson WC; Szefler SJ
    Ann Allergy Asthma Immunol; 2019 Apr; 122(4):367-372. PubMed ID: 30703438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives of childhood asthma treatment with biologics.
    Just J; Deschildre A; Lejeune S; Amat F
    Pediatr Allergy Immunol; 2019 Mar; 30(2):159-171. PubMed ID: 30444939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety, durability of response, cessation and switching of biologics.
    Mohan A; Qiu AY; Lugogo N
    Curr Opin Pulm Med; 2024 May; 30(3):303-312. PubMed ID: 38426355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
    Rogers L; Jesenak M; Bjermer L; Hanania NA; Seys SF; Diamant Z
    Respir Med; 2023 Nov; 218():107414. PubMed ID: 37776915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.